Establishment of a prognostic signature for patients with advanced lung squamous cell carcinoma based on tumor-infiltrating immune cells.

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-545/coif). The authors have no conflicts of interest to declare."

"Funding: This work was supported by the National Natural Science Foundation of China ( Nos. 82172569, 82072595 and 61973232 ); Tianjin Key Medical Discipline (Specialty) Construction Project ( No. TJYXZDXK-061B ); Tianjin Health Science and Technology Project ( Nos. TJWJ2022XK005, ZC20179 ); Beijing Science and Technology Innovation Medical Development Fund ( No. KC2021-JX-0186-57 ). The funders had no role in study design, data collection and analysis, decision to publish, or in the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or in the preparation of the manuscript."